Single-Cell Analysis Market is set to be driven by the expansion of Oncology and Life Science Research

1
Single-Cell Analysis Market is set to be driven
by the expansion of Oncology and Life Science
Research
2
Single-cell technologies allow the examination of
differences between individual cells instead of
the averaged signal obtained is the case of bulk
samples. Global Single-Cell Analysis Market is
estimated at 2.1 Bn (2020) growing at a CAGR of
17.8 through 2020-2025. The expansion of
oncology and life science research is the factor
driving the market growth. Single-cell analysis
A potential oncology research tool Single-cell
analysis is emerging as powerful tool for cancer
research. It characterizes the molecular state of
each tumor cell, enabling exploration of tumor
heterogeneity, microenvironment cell-type
composition, and cell state transitions that
affect therapeutic response, particularly in the
context of immunotherapy. The demand for products
used in single-cell analysis is projected to
increase due to the increased incidence of
various forms of cancer and the expansion of
cancer research projects. Bulk sequencing can
explain the most common mutations in tumor, but
single-cell DNA multi-omics offer insights on
which mutations occur at single-cell level. Drug
developers are increasingly using single-cell
analysis to prioritize targets and pathways for
new therapies, demonstrate therapeutic efficacy,
and understand resistance mechanisms - Global
Research Head, Leading Pharmaceutical Company
3

• Investor funding is providing impetus for
  single-cell technology
• Single-cell analysis has become a vital tool for
  scientific research. Investors are providing
  funding to companies that are developing products
  or solutions for single-cell analysis, citing the
  potential for advancement.
• For instance,
• In November 2021, Singleron Biotechnologies, a
  start-up company developing single-cell
  multi-omics products raised 100 million to
  ramp up products development and augment
  international presence.
• Further, in October 2021, Sphere
  Fluidics received 40 million to expand
  international sales activities for its
  single-cell analysis systems that use proprietary
  picodroplet technology.
• Explore Premium Report on Single-Cell Analysis
  Market _at_ https//meditechinsights.com/single-cell-
  analysis-market/
• Analysis of complex and richer datasets may
  present challenge
• In comparison to bulk sequencing, single-cell
  sequencing methods generate datasets that are
  more complex and richer. The increased complexity
  might result in misunderstandings and wrong
  conclusions. However, advances in data analytics
  as well as the use of machine learning/AI to data
  analysis are increasingly being used to overcome
  these challenges.

4
Regional Adoption Single-Cell Analysis
Market Comprehensive regional assessment of the
global single-cell analysis market suggests that
US is currently the largest market for
single-cell analysis. The U.S. has a large number
of biotech companies and research institutions,
and it enjoys greater funding for life science
research. Also, the U.S. led global VC investment
in biotech sector in 2020, followed by Europe and
China. The Asia-Pacific single-cell analysis
market dominated by China is expanding more
quickly compared to other regions. Competitive
Landscape Analysis of Single-Cell Analysis
Market Some of the key players in global
single-cell analysis market are Becton, Dickinson
and Company, Danaher, Merck, Thermo Fisher,
Qiagen, 10X Genomics, Fluidigm, Promega,
Illumina, Bio-Rad Laboratories, and Luminex. For
More Comprehensive Insights, Contact Us
_at_ https//meditechinsights.com/contact-us/ About
Medi-Tech Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com